Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Signalling protein complexes isolated from primary human skin‐resident T cells can be analysed by Multiplex IP‐FCM
Smith, Stephen , Neier, Steven C. , Davis, Tessa R. , Pittelkow, Mark R. , Gil, Diana , Schrum, Adam G. , Smith, Stephen E P, Schrum, Adam G

Experimental Dermatology | March 3, 2014 | Volume: 23 | Issue: 4 | Pages: 272-273

10.1111/exd.12362 | PMID 24588717 Get It

AbstractStudying signal transduction in skin‐resident T cells (sr‐T cells) can be limited by the small size of clinical biopsies. Here, we isolated sr‐T cells from clinical samples and analysed signalling protein complexes by multiplex immunoprecipitation detected by flow cytometry (mIP‐FCM). In samples from two independent donors, antigenic stimulation induced signalling proteins to join shared complexes that were observed in seven pairwise combinations among five proteins. This demonstrates that sr‐T cells isolated from small clinical samples provide sufficient material for mIP‐FCM‐based analysis of signalling‐induced protein complexes. We propose that this strategy may be useful for gaining improved mechanistic insight of sr‐T cell signal transduction associated with dermatological disease.
Biobanks and personalized medicine
Bielinski, Suzette J. , Ryu, Euijung , Winkler, Erin, Takahashi, Paul Y. , Pathak, Jyotishman , Cerhan, James R. , Olson, Janet E. , Cerhan, James R , Bielinski, Suzette , Takahashi, Paul

Clinical Genetics | March 3, 2014 | Volume: 86 | Issue: 1 | Pages: 50-55

10.1111/cge.12370 | PMID 24588254 Get It

AbstractWe provide a mini‐review of how biobanks can support clinical genetics in the era of personalized medicine. We discuss types of biobanks, including disease specific and general biobanks not focused on one disease. We present considerations in setting up a biobank, including consenting and governance, biospecimens, risk factor and related data, informatics, and linkage to electronic health records for phenotyping. We also discuss the uses of biobanks and ongoing considerations, including genotype‐driven recruitment, investigations of gene–environment associations, and the re‐use of data generated from studies. Finally, we present a brief discussion of some of the unresolved issues, such as return of research results and sustaining biobanks over time. In summary, carefully designed biobanks can provide critical research and infrastructure support for clinical genetics in the era of personalized medicine.
Approximately one‐half of patients with early‐stage hepatocellular carcinoma meeting Milan criteria did not receive local tumor destructive or curative surgery in the post‐MELD exception era
Devaki, Pardha, Wong, Robert J. , Marupakula, Vidyasagargoud, Nangia, Sharad, Ditah, Ivo, Ehrinpreis, Murray N., Nguyen, Mindie H. , Nguyen, Long H. , Wong, Robert J

Cancer | March 3, 2014 | Volume: 120 | Issue: 11 | Pages: 1725-1732

10.1002/cncr.28639 | PMID 24590359 Get It

BACKGROUNDSince 2002, priority Model for End‐stage Liver Disease (MELD) exception status has been given to patients with hepatocellular carcinoma (HCC) who meet the Milan criteria. Since then, the number of liver transplantations performed in patients with HCC has increased, but to the authors' knowledge, few studies to date have examined the effect of MELD exception recommendations on therapy use and survival rates in a nationwide sample. The current study examines therapy use and long‐term survival rates among patients with HCC tumors meeting the Milan criteria in the post‐MELD exception era.METHODSThe current study is a retrospective cohort study of 2179 patients with localized HCC meeting the Milan criteria who were registered between 2004 and 2007 in the Surveillance, Epidemiology, and End Results database.RESULTSA total of 43% of patients did not receive any specific therapy. Overall, the 5‐year relative survival rate for patients receiving only supportive care was dismal at 24% (95% confidence interval [95% CI], 21%‐27%), whereas that for patients undergoing liver transplantation was 77% (95% CI, 71%‐82%). Long‐term survival was found to be dependent on age, race/ethnicity, and type of therapy received. A multivariate Cox proportional hazards model adjusted for age, race/ethnicity, and type of therapy received demonstrated that, compared with white patients, black patients had significantly poorer survival outcomes (hazards ratio, 1.23; 95% CI, 1.03‐1.47 [P = .02]), whereas Asian/Pacific Islander patients had significantly better survival rates when compared with white patients (HR, 0.66; 95% CI, 0.57‐0.77 [P < .001]).CONCLUSIONSDespite having localized disease that met transplantation criteria, nearly 50% of the large nationwide cohort of patients with HCC in the current study received only supportive care and had dismal 5‐year relative survival rates, especially among black patients. Cancer 2014;120:1725–1732. © 2014 American Cancer Society.
Faculty Opinions recommendation of Lifespan of effector memory CD4+ T cells determined by replication-incompetent integrated HIV-1 provirus.
Badley, Andrew D. , Cummins, Nathan W.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | March 3, 2014 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.718264442.793491515 Get It

Complex IGH rearrangements in multiple myeloma: Frequent detection discrepancies among three different probe sets
Kim, Gina Y., Gabrea, Ana, Demchenko, Yulia N. , Bergsagel, Leif, Roschke, Anna V. , Kuehl, W. Michael, Bergsagel, P. Leif , Bergsagel, P. Leif

Genes, Chromosomes and Cancer | March 3, 2014 | Volume: 53 | Issue: 6 | Pages: 467-474

10.1002/gcc.22158 | PMID 24585545 Get It

Primary IGH translocations involving seven recurrent partner loci and oncogenes are present in about 40% of multiple myeloma tumors. Secondary IGH rearrangements, which occur in a smaller fraction of tumors, usually are complex structures, including insertions or translocations that can involve three chromosomes, and often with involvement of MYC. The main approach to detect IGH rearrangements is interphase—but sometimes metaphase—FISH strategies that use a telomeric variable region probe and a centromeric constant region/ Eα enhancer or 3′ flanking probe to detect a separation of these two probes, or a fusion of these probes with probes located at nonrandom partner sites in the genome. We analyzed 18 myeloma cell lines for detection discrepancies among Vysis, Cytocell, and in‐house IGH probe sets that hybridize with differing sequences in the IGH locus. There were no detection discrepancies for the three telomeric IGH probes, or for unrearranged IGH loci or primary IGH translocations using the centromeric IGH probes. However, the majority of complex IGH rearrangements had detection discrepancies among the three centromeric IGH probes. © 2014 Wiley Periodicals, Inc.
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study
Wang, Michael , Popplewell, Leslie , Collins, Robert H. , Winter, Jane N. , Kaminski, Mark , Bartlett, Nancy L. , Johnston, Patrick B. , Lister, John , Fanning, Suzanne, Tuscano, Joseph M. , Robeva, Anna, Fan, Jenna, Klimovsky, Judith, Cheung, Wing, Cherfi, Azzeddine , O’Connor, Owen A. , Goy, Andre Henri , Beck, J. Thaddeus , Kaya, Hakan , Bartlett, Nancy L , Winter, Jane N

British Journal of Haematology | March 3, 2014 | Volume: 165 | Issue: 4 | Pages: 510-518

10.1111/bjh.12780 | PMID 24579926 Get It

Reinventing the Case Study for Community Health and Primary Care Research
Rohrer, James E.

Journal of Primary Care & Community Health | March 3, 2014 | Volume: 5 | Issue: 2 | Pages: 78-79

10.1177/2150131914522735 | PMID 24591514 Get It

Venous Thromboembolism after Urological Surgery
Tyson, Mark D. , Castle, Erik P., Humphreys, Mitchell R. , Andrews, Paul E.

Journal of Urology | March 2, 2014 | Volume: 192 | Issue: 3 | Pages: 793-797

10.1016/j.juro.2014.02.092 | PMID 24594402 Get It

Pathogeneses of Sudden Cardiac Death in National Collegiate Athletic Association Athletes
Maleszewski, Joseph J. , Lopez-Anderson, Martha, Owens, David S. , Prutkin, Jordan M. , Asif, Irfan M. , Klossner, David, Ackerman, Michael J. , Harmon, Kimberly G. , Drezner, Jonathan A.

Circulation: Arrhythmia and Electrophysiology | March 2, 2014 | Volume: 7 | Issue: 2 | Pages: 198-204

10.1161/circep.113.001376 | PMID 24585715 Get It

Background— The pathogenesis of sudden cardiac death in college athletes has not been defined by systematic case identification. Methods and Results— A total of 45 cases of sudden cardiac death were identified in National Collegiate Athletic Association (NCAA) athletes from 2004 to 2008 based on an internal reporting system and review of media reports. Autopsy reports were reviewed and adjudicated by a multidisciplinary panel. Cause of death could be reasonably determined in 36 cases; 3 athletes had no autopsy, 5 autopsy reports could not be obtained, and 1 autopsy had insufficient information to determine cause of death. The most common finding at death was a structurally normal heart or autopsy-negative sudden unexplained death (11, 31%), followed by coronary artery abnormalities (5, 14%), dilated cardiomyopathy (3, 8%), myocarditis related (3, 8%), aortic dissection (3, 8%), and idiopathic left ventricular hypertrophy/possible hypertrophic cardiomyopathy (HCM; 3, 8%). There was 1 case each (3%) of hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy, long QT syndrome, commotio cordis, and Kawasaki disease. There was 1 case of death in a sickle cell positive athlete who also had left ventricular hypertrophy. The adjudicated diagnosis agreed with the official pathology report in only 59% of cases. Conclusions— Unexplained death with a structurally normal heart is the most common finding after suspected sudden cardiac death in NCAA athletes. Hypertrophic cardiomyopathy is infrequently seen, and conclusions in autopsy reports may not accurately reflect the pathological findings. Standardized protocols for cardiovascular autopsies in athletes are needed, including postmortem genetic testing, particularly in autopsy-negative cases.
Intraoperative image-guided spinal navigation: technical pitfalls and their avoidance
Rahmathulla, Gazanfar , Nottmeier, Eric W. , Pirris, Stephen M. , Deen, H. Gordon , Pichelmann, Mark A.

Neurosurgical Focus | March 1, 2014 | Volume: 36 | Issue: 3 | Pages: E3

10.3171/2014.1.focus13516 | PMID 24580004 Get It

Spinal instrumentation has made significant advances in the last two decades, with transpedicular constructs now widely used in spinal fixation. Pedicle screw constructs are routinely used in thoracolumbar-instrumented fusions, and in recent years, the cervical spine as well. Three-column fixations with pedicle screws provide the most rigid form of posterior stabilization. Surgical landmarks and fluoroscopy have been used routinely for pedicle screw insertion, but a number of studies reveal inaccuracies in placement using these conventional techniques (ranging from 10% to 50%). The ability to combine 3D imaging with intraoperative navigation systems has improved the accuracy and safety of pedicle screw placement, especially in more complex spinal deformities. However, in the authors' experience with image guidance in more than 1500 cases, several potential pitfalls have been identified while using intraoperative spinal navigation that could lead to suboptimal results. This article summarizes the authors' experience with these various pitfalls using spinal navigation, and gives practical tips on their avoidance and management.